1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name | Common Trade Name(s) |
Classification![]() |
Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Drotrecogin alfa | Xigris | Antithrombotic profibrinolytic anti-inflammatory enzyme | 2011/10/25 |
Caplacizumab | Cablivi | Antithrombotic agent | 2020/09/04 |
Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide | Genvoya | Antiretroviral agents | 2016/02/03 |
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil fumarate | Stribild | Antiretroviral agent | 2012/12/20 |
Emtricitabine + tenofovir | Descovy | Antiretroviral agent | 2016/06/03 |
Cabotegravir | Vocabria | Antiretroviral agent | 2020/03/19 |
Cabotegravir + rilpivirine | Cabenuva | Antiretroviral agent | 2020/03/19 |
Aripiprazole | Abilify | Antipsychotic agent | 2009/07/03 |
Paliperidone palmitate | Invega Sustenna | Antipsychotic agent | 2010/07/28 |
Paliperidone | Invega | Antipsychotic agent | 2007/10/02 |
Brexpiprazole | Rexulti | Antipsychotic agent | 2017/04/20 |
Prasugrel | Effient | Antiplatelet agent | 2020/01/31 |
Aluminum chloride hexahydrate | Hydrosal gel | Antiperspirant | |
Rotigotine | Neupro | Antiparkinsonian agent / Dopamine agonist | 2013/09/12 |
Brolucizumab | Beovu | Antineovascularisation agent | 2020/05/15 |
Pomalidomide | Pomalyst | Antineoplastic agent; immunmodulator | 2014/02/24 |
Daratumumab | Darzalex SC | Antineoplastic agent, monoclonal antibody | 2020/08/12 |
Isatuximab | Sarclisa | Antineoplastic agent, monoclonal antibody | 2020/07/03 |
Enasidenib | IDHIFA | Antineoplastic agent / IDH2 Inhibitor | 2019/02/27 |
Degarelix | Firmagon | Antineoplastic agent | 2009/11 |
Lapatinib ditosylate | Tykerb | Antineoplastic agent | 2009/05 |
Azacitidine | Vidaza | Antineoplastic agent | 2009/12/07 |
Everolimus | Afinitor | Antineoplastic agent | 2010/02/12 |
Trabectedin | Yondelis | Antineoplastic agent | 2010/08/04 |
Lenalidomide | Revlimid | Antineoplastic agent | |
Pazopanib | Votrient | Antineoplastic agent | 2011/08/25 |
Ipilimumab | Yervoy | Antineoplastic agent | 2012/03 |
Cabazitaxel | Jevtana | Antineoplastic agent | 2011/06 |
Eribulin | Halaven | Antineoplastic agent | 2012/03/10 |
Ruxolitinib | Jakavi | Antineoplastic agent | 2012/07/18 |
Ofatumumab | Arzerra | Antineoplastic agent | 2012/03/09 |
Vemurafenib | Zelboraf | Antineoplastic agent | 2012/02 |
Pertuzumab | Perjeta | Antineoplastic agent | 2013/04/23 |
Regorafenib | Stivarga | Antineoplastic agent | 2013/03/11 |
Trastuzumab emtansine | Kadcyla | Antineoplastic agent | 2013/09/27 |
Bendamustine | Treanda | Antineoplastic agent | 2012/09/12 |